395
Citations
106
Journals
2012
First Cited
2022
Last Cited

Articles citing This Document (Page 2 of 8)

ArticleJournalYear
Caffeine and Methylliberine: A Human Pharmacokinetic Interaction Study2022
Effect of cenobamate on the single-dose pharmacokinetics of multiple cytochrome P450 probes using a cocktail approach in healthy subjectsClinical and Translational Science2021
Application of Physiologically Based Pharmacokinetic Modeling to Evaluate the Drug-Drug and Drug-Disease Interactions of ApatinibFrontiers in Pharmacology2021
In Vitro/In Vivo Correlation for Drug-Drug Interactions2020
Non-vitamin K antagonist oral anticoagulants and sportMinerva Cardioangiologica2020
HPLC methods of fexofenadine quantitative analysis in rabbits’ liverFarmatsiya I Farmakologiya2020
Strategies for Incorporating Pharmacokinetic Studies into Oncology Phase I Trials2020
The possibility of prognosis of progesterone preparations interactionRussian Journal of Human Reproduction2018
6. Role of Regulatory Science in New Drug Evaluation : Clinical Pharmacology and PharmacokineticsJapanese Journal of Clinical Pharmacology and Therapeutics2018
Some Methodologic Considerations in the Assessment of Methods for Predicting Pharmacokinetic Drug-Drug InteractionsClinical Pharmacology in Drug Development2017
INFLUENCE OF VILDAGLIPTIN AND GLIQUIDONE COMBINATION ON P-GLYCOPROTEIN FUNCTIONAL ACTIVITY AND EXPRESSION ON THE BACKGROUND OF NORM AND IN EXPERIMENTAL ALLOXAN-INDUCED DIABETES MELLITUS TYPE 2I P Pavlov Russian Medical Biological Herald2016
IN SILICO MODELING OF METABOLITE KINETICS
Views on the Therapeutic Needs of Older AdultsAAPS Advances in the Pharmaceutical Sciences Series2016
Summary Report of Questionnaire Survey on Current Situation and Issues of Human Mass Balance Study Using Radioisotopes in JapanJapanese Journal of Clinical Pharmacology and Therapeutics2015
Renal Organic Cation and Anion Transport: From Physiology to Genes☆2014
Evaluation of Time-Dependent CYP3A4 Inhibition Using Human HepatocytesMethods in Pharmacology and Toxicology2014
In Vitro Characterization of Intestinal Transporter, Breast Cancer Resistance Protein (BCRP)Methods in Pharmacology and Toxicology2014
In Vitro CYP Induction Using Human HepatocytesMethods in Pharmacology and Toxicology2014
In Vitro Characterization of Renal Transporters OAT1, OAT3, and OCT2Methods in Pharmacology and Toxicology2014
Membrane Transporters in ADMEAAPS Advances in the Pharmaceutical Sciences Series2013
In Vitro Kinetic Characterization of Transporter-Mediated PermeabilityAAPS Advances in the Pharmaceutical Sciences Series2013
Drug-transporter interaction testing in drug discovery and developmentWorld Journal of Pharmacology2013
Pharmacokinetic drug interactions in liver disease: An updateWorld Journal of Gastroenterology2016
Drug-Drug Interactions of P-gp Substrates Unrelated to CYP MetabolismCurrent Drug Metabolism2019
Co-Prescription of QT-Interval Prolonging Drugs: An Analysis in a Large Cohort of Geriatric PatientsPLoS ONE2016
Identification and Evaluation of Clinical Substrates of Organic Anion Transporting Polypeptides 1B1 and 1B3Clinical and Translational Science2019
Irreversible enzyme inhibition kinetics and drug-drug interactionsMethods in Molecular Biology2014
Reversible mechanisms of enzyme inhibition and resulting clinical significanceMethods in Molecular Biology2014
Case study 4. Predicting the drug interaction potential for inhibition of CYP2C8 by montelukastMethods in Molecular Biology2014
Pharmacokinetics and ADME characterizations of antibody-drug conjugatesMethods in Molecular Biology2013
Pharmacogenetics of membrane transporters: a review of current approachesMethods in Molecular Biology2014
Prediction of Hepatic Transporter-Mediated Drug–Drug Interaction from In Vitro DataAAPS Advances in the Pharmaceutical Sciences Series2013
The Role of Transporters in Drug Development: Regulatory Science Perspectives from the FDAAAPS Advances in the Pharmaceutical Sciences Series2013
INTEGRATED REACTIVE METABOLITE STRATEGIES
Evaluation of iberdomide and cytochrome p450 drug-drug interaction potential in vitro and in a phase 1 study in healthy subjectsEuropean Journal of Clinical Pharmacology2021
The Effect of CYP3A Induction and Inhibition on the Pharmacokinetics of Laquinimod, a Novel NeuroimmunomodulatorClinical Pharmacology in Drug Development2020
Drug Interactions in the Liver2020
Replacing the eleven native tryptophans by directed evolution produces an active P-glycoprotein with site-specific, non-conservative substitutionsScientific Reports2020
Induction of Cytochrome P450 Systems2020
Combinations of common SNPs of the transporter gene ABCB1 influence apparent bioavailability, but not renal elimination of oral digoxinScientific Reports2020
Drug–Drug Interaction Studies2020
Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6Pharmacology Research and Perspectives2020
Update on Therapeutic Protein-Drug Interaction: Information in LabelingClinical Pharmacokinetics2020
Assessment of CYP-Mediated Drug Interactions for Evocalcet, a New Calcimimetic Agent, Based on In Vitro Investigations and a Cocktail Study in HumansClinical and Translational Science2019
Influence of Multidrug Resistance-Associated Proteins on the Excretion of the ABCC1 Imaging Probe 6-Bromo-7-[C]Methylpurine in MiceMolecular Imaging and Biology2019
Lack of Effect of 12-Week Treatment with Risankizumab on the Pharmacokinetics of Cytochrome P450 Probe Substrates in Patients with Moderate to Severe Chronic Plaque PsoriasisClinical Pharmacokinetics2019
Mass Balance and Drug Interaction Potential of Intravenous Eravacycline Administered to Healthy SubjectsAntimicrobial Agents and Chemotherapy2019
Physiologically-Based Pharmacokinetic Models for CYP1A2 Drug-Drug Interaction Prediction: A Modeling Network of Fluvoxamine, Theophylline, Caffeine, Rifampicin, and MidazolamCPT: Pharmacometrics and Systems Pharmacology2019
Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy SubjectsClinical Drug Investigation2019
EASL Clinical Practice Guidelines: Drug-induced liver injuryJournal of Hepatology2019
Non randomized study on the potential of nitisinone to inhibit cytochrome P450 2C9, 2D6, 2E1 and the organic anion transporters OAT1 and OAT3 in healthy volunteersEuropean Journal of Clinical Pharmacology2019
Considerations for Biologic Product Drug-Drug Interactions: A Regulatory PerspectiveClinical Pharmacology and Therapeutics2019
Organic Anion Transporter Polypeptide 1B1 Polymorphism Modulates the Extent of Drug-Drug Interaction and Associated Biomarker Levels in Healthy VolunteersClinical and Translational Science2019
Herb-drug interactions: a novel algorithm-assisted information system for pharmacokinetic drug interactions with herbal supplements in cancer treatmentEuropean Journal of Clinical Pharmacology2019
Does In Vitro Cytochrome P450 Downregulation Translate to In Vivo Drug-Drug Interactions? Preclinical and Clinical Studies With 13-cis-Retinoic AcidClinical and Translational Science2019
A Clinical Drug-Drug Interaction Study Assessing a Novel Drug Transporter Phenotyping Cocktail With Adefovir, Sitagliptin, Metformin, Pitavastatin, and DigoxinClinical Pharmacology and Therapeutics2019
Physiologically-Based Pharmacokinetic Modeling Approach to Predict Rifampin-Mediated Intestinal P-Glycoprotein InductionCPT: Pharmacometrics and Systems Pharmacology2019
Effect of Fluconazole Coadministration and CYP2C9 Genetic Polymorphism on Siponimod Pharmacokinetics in Healthy SubjectsClinical Pharmacokinetics2019
FDA Public Meeting Report on "Drug Interactions With Hormonal Contraceptives: Public Health and Drug Development Implications"Journal of Clinical Pharmacology2018
In Vitro/In Vivo Correlation for Drug-Drug Interactions2018
Effect of OATP1B1/1B3 Inhibitor GDC-0810 on the Pharmacokinetics of Pravastatin and Coproporphyrin I/III in Healthy Female SubjectsJournal of Clinical Pharmacology2018
Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady-state disposition of lamotrigine in adults with epilepsyBritish Journal of Clinical Pharmacology2018
CYP3A4-mediated effects of rifampicin on the pharmacokinetics of vilaprisan and its UGT1A1-mediated effects on bilirubin glucuronidation in humansBritish Journal of Clinical Pharmacology2018
Inhibitory Effects of Commonly Used Excipients on P-Glycoprotein in VitroMolecular Pharmaceutics2018
A Novel PBPK Modeling Approach to Assess Cytochrome P450 Mediated Drug-Drug Interaction Potential of the Cytotoxic Prodrug EvofosfamideCPT: Pharmacometrics and Systems Pharmacology2018
Drug Interactions With New Synthetic OpioidsFrontiers in Pharmacology2018
Experimental Studies of the Effects of Progesterone on the Functional Activity of P-GlycoproteinPharmaceutical Chemistry Journal2018
Renal Organic Cation and Anion Transport: From Physiology to Genes2018
In Vitro and In Vivo Investigation of Potential for Complex CYP3A Interaction for PF-00251802 (Dagrocorat), a Novel Dissociated Agonist of the Glucocorticoid ReceptorClinical Pharmacology in Drug Development2018
Development of Guanfacine Extended-Release Dosing Strategies in Children and Adolescents with ADHD Using a Physiologically Based Pharmacokinetic Model to Predict Drug-Drug Interactions with Moderate CYP3A4 Inhibitors or InducersPaediatric Drugs2018
Prediction of Drug-Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically-Based Pharmacokinetic ModellingBasic and Clinical Pharmacology and Toxicology2018
Effects of rifampin, itraconazole and esomeprazole on the pharmacokinetics of alisertib, an investigational aurora a kinase inhibitor in patients with advanced malignanciesInvestigational New Drugs2018
Clinical evaluation of P-glycoprotein inhibition by venetoclax: a drug interaction study with digoxinXenobiotica2018
Drug interactions between non-rifamycin antibiotics and hormonal contraception: a systematic reviewAmerican Journal of Obstetrics and Gynecology2018
In vitro drug-drug interactions of budesonide: inhibition and induction of transporters and cytochrome P450 enzymesXenobiotica2018
Effects of Metformin and Furosemide on Rosuvastatin Pharmacokinetics in Healthy Volunteers: Implications for Their Use as Probe Drugs in a Transporter CocktailEuropean Journal of Drug Metabolism and Pharmacokinetics2018
In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450Xenobiotica2018
Transport properties of valsartan, sacubitril and its active metabolite (LBQ657) as determinants of dispositionXenobiotica2018
Interpretation, Integration, and Implementation of In Vitro Assay Data: The Predictive Toxicity ChallengeMethods in Pharmacology and Toxicology2018
Relationships of Changes in Pharmacokinetic Parameters of Substrate Drugs in Drug-Drug Interactions on Metabolizing Enzymes and TransportersJournal of Clinical Pharmacology2018
Effects of a Fixed-Dose Co-Formulation of Daclatasvir, Asunaprevir, and Beclabuvir on the Pharmacokinetics of a Cocktail of Cytochrome P450 and Drug Transporter Substrates in Healthy SubjectsDrugs in R and D2018
Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011-2017: Lessons Learned for Anticancer Drug DevelopmentClinical and Translational Science2018
In vitro studies and in silico predictions of fluconazole and CYP2C9 genetic polymorphism impact on siponimod metabolism and pharmacokineticsEuropean Journal of Clinical Pharmacology2018
Pharmacokinetic/pharmacodynamic drug-drug interactions of avatrombopag when coadministered with dual or selective CYP2C9 and CYP3A interacting drugsBritish Journal of Clinical Pharmacology2018
Pharmacokinetic Drug Interaction Study of Bazedoxifene and IbuprofenClinical Pharmacology in Drug Development2018
Development of a Physiologically Based Pharmacokinetic Model for Sinogliatin, a First-in-Class Glucokinase Activator, by Integrating Allometric Scaling, In Vitro to In Vivo Exploration and Steady-State Concentration-Mean Residence Time Methods: Mechanistic Understanding of its PharmacokineticsClinical Pharmacokinetics2018
Novel Application of the Two-Period Microtracer Approach to Determine Absolute Oral Bioavailability and Fraction Absorbed of ErtugliflozinClinical and Translational Science2018
Bidirectional Pharmacokinetic Interaction Between Amodiaquine and Pioglitazone in Healthy SubjectsJournal of Clinical Pharmacology2018
The drug interaction potential of daprodustat when coadministered with pioglitazone, rosuvastatin, or trimethoprim in healthy subjectsPharmacology Research and Perspectives2018
Effects of Ketoconazole and Rifampicin on the Pharmacokinetics of Nintedanib in Healthy SubjectsEuropean Journal of Drug Metabolism and Pharmacokinetics2018
Disease-Drug Interactions in Inflammatory States via Effects on CYP-Mediated Drug ClearanceJournal of Clinical Pharmacology2018
The Role of Transporters in Drug Accumulation and Mitochondrial Toxicity2018
Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infectionPLoS ONE2017
Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and TherapeuticsDrug Safety - Case Reports2017
Validation of a total IC method which enables in vitro assessment of transporter inhibition under semi-physiological conditionsXenobiotica2017
Selexipag in Pulmonary Arterial Hypertension: Most Updated Evidence From Recent Preclinical and Clinical StudiesJournal of Clinical Pharmacology2017
Unbound liver concentration is the true inhibitor concentration that determines cytochrome P450-mediated drug-drug interactions in rat liverXenobiotica2017
Metabolic profile and pharmacokinetics of polyphyllin I, an anticancer candidate, in rats by UPLC-QTOF-MS/MS and LC-TQ-MS/MSBiomedical Chromatography2017
Pharmacokinetics of Venetoclax, a Novel BCL-2 Inhibitor, in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Non-Hodgkin LymphomaJournal of Clinical Pharmacology2017
Clinical Pharmacokinetics and Pharmacodynamics of AfatinibClinical Pharmacokinetics2017